MYD88 and breast cancer: conducted baseline expression level assessments of MyD88 in various breast cancer cell lines, including MCF7, SKBR3, MDA-MB-231, and BT-474, and found that MyD88 mRNA level was highest in MCF-7 cells (22, 27).